By first confirming the under-expression of miR-141 in PCa stem/progenitor populations, here we show that miR-141 is most highly under-expressed (compared with the other three miRNAs) in patient tumour-derived CD44+ HPCa cells (Fig. 1c, 14). The gene discussed is CD44; the disease is posterior cortical atrophy.